Beranda › Asma › Wisconsin › Milwaukee
Uji klinis Asma di Milwaukee, WI
4 studi untuk Asma mencari peserta di lokasi sekitar Milwaukee (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Menerima pesertaFase 3
- GSK Investigational Site, Milwaukee
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Menerima pesertaFase 2
- Research Site, Milwaukee
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Menerima pesertaFase 3
- Teva Investigational Site 12062, Greenfield · 8 mi jauhnya
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Menerima pesertaStudi observasional
- Allergy, Asthma & Sinus Center, S.C., Greenfield · 8 mi jauhnya
Uji klinis Asma di kota lain
- Miami, FL12 studi
- New York City, NY11 studi
- Boston, MA11 studi
- Oklahoma City, OK10 studi
- Durham, NC10 studi
- Dallas, TX10 studi
- Washington, DC9 studi
- The Bronx, NY9 studi
- Kansas City, KS8 studi
- Houston, TX8 studi
- St. Louis, MO7 studi
- Pittsburgh, PA7 studi
Studi lain di Milwaukee
- Kanker Payudara23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Kanker (semua jenis)22 studi
- Kanker Paru21 studi
- Mieloma Multipel21 studi
- Kanker Prostat20 studi
- Limfoma Folikuler19 studi
- Kanker Pankreas18 studi
- Limfoma Non-Hodgkin18 studi
- Kanker Ovarium17 studi
- Leukemia Mieloid Akut17 studi
- Limfoma Burkitt16 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.